Steven Hyman
Director · Voyager Therapeutics, Inc.
Individual
- 2026
- Jun 11, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Steven Hyman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alfred Sandrock - $184K in VYGR purchases and sales in the last 12 months
- Robin Swartz - $55K in VYGR purchases and sales in the last 12 months
- Todd Alfred Carter - $41K in VYGR purchases and sales in the last 12 months
- Nathan D. Jorgensen - $18K in VYGR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Steven Hyman?
Steven Hyman is a corporate insider, tracked as Director of Voyager Therapeutics, Inc. (VYGR). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Steven Hyman last file a Form 4?
The only primary Form 4 on record is dated 11 June 2026.